Apple is Developing Sensors for Apple Watch to Monitor Diabetes

Apple is Developing Sensors for Apple Watch to Monitor Diabetes

Apple is Developing Sensors for Apple Watch to Monitor Diabetes

CNBC further reports that it is a completely confidential and closed operation, employing just 30 people including some Apple Watch team members and biomedical experts from companies such as Vital Connect, Masimo Corp, Sano, Medtronic, and C8 Medisensors.

According to the report, Apple has been working for at least five years to develop such biomedical devices.

The sensors being developed are slated to work noninvasively and continuously in monitoring blood sugar levels.

The engineers are said to be working from a nondescript office in Palo Alto, around 15 miles away from the new Apple corporate headquarters in Cupertino, California.

Success in the above field will no doubt also infuse new life in the smart wearable segment such as the Apple Watch.

Space expert John L. Smith described the development of a method to accurately measure blood sugar levels without drawing blood from patients as "the most hard technical challenge I have encountered in my career".

Apple is reportedly working on sensors created to monitor blood sugar levels through contact with the skin, according to an article from CNBC. One big chronic disease nowadays is Diabetes.

Apple is also working on optical sensors that work by shining a light through the patient skin to test glucose levels, explained by another source.

About 29 million people, or more than 9 percent of the population of the United States alone, were believed to have diabetes as of 2014, with a staggering 8.1 million people undiagnosed.

In the event that Apple can, in some way or other, develop where many companies have not been able to, then it will make the number of individuals who have the motivation to buy a Watch increase greatly.

Heart rate monitoring is now fairly ubiquitous, and the new Garmin Vivosmart 3 is one of several fitness trackers with the ability to measure vo2max, but blood glucose is still proving a tough a nut to crack.

Apple is the latest in a line of companies going back years that have tried to crack the challenge. The report claims that that project has reached a point where Apple is pursuing feasibility trials and hiring people to help the company navigate the FDA's regulatory process.

Related news